ALK and non-small cell lung carcinoma: Different NGS methodologies, such as amplicon-based ctDNA NGS [183,184] or hybrid-capture techniques [185,186,187,188,189,190], have been mostly used in several studies for the detection of ALK rearrangements in newly diagnosed NSCLC patients or those who relapsed after targeted treatment.